In Summary To summarise briefly what has been covered in this blog post: Incretin-based therapeutics are changing the treatment landscape in many diseases such as diabetes, obesity, as well as in organs like the heart, liver, kidneys and brain Tools and biomarkers (like imaging) can provide helpful insights to further our understanding of how incretins work The future for incretin-based therapies is bright with options for novel combinations and expansion into new indications and disease areas Blog disclaimer The views and opinions expressed in this article are solely those of the contributing author/s
A STAT investigation identified more than 100 telehealth sites marketing GLP-1 medications such as semaglutide and tirzepatide
In an era where bioactive compounds are a click away, patients will increasingly run real-world experiments ahead of our evidence base
After hair removal and disinfection of the abdomen, a 10-mm midline laparotomy was performed, and the cecum exposed
Anti-Inflammatory Effects: BPC-157 exhibits strong anti-inflammatory properties, helping to reduce the chronic inflammation that often impedes healing in conditions like arthritis or tendonitis
